WHO 2022 Guidelines Mini Reviews
This collection of mini reviews aims to address various changes outlined in the 2022 WHO guideline on endocrine tumour classification. These reviews are crucial for keeping up to date with the evolving standards in the field.
We welcome contributions to this collection
Endocrine-Related Cancer publishes the latest in high quality work across all aspects of endocrine oncology. However, we understand that in some cases, emerging themes may not yet be suitable for a full review article. We therefore welcome submissions of mini-reviews to this collection. Articles should be concise, informative, and no more than 3000 words in length, with limited references and figures and be accompanied by a graphical abstract where possible.
If you are interested in contributing, please submit an article proposal to erc@bioscientifica.com, or include one within the cover letter of your submission.
Published articles:
The World Health Organization classifications of pituitary neuroendocrine tumours: a clinico-pathological appraisal
Chiara Villa, Bertrand Baussart, Guillaume Assié, Gerald Raverot and Federico Roncaroli
The 2022 WHO classification of thyroid tumors: novel concepts in nomenclature and grading
C Christofer Juhlin, Ozgur Mete, and Zubair W Baloch
Changes in categorization or nomenclature within neuroendocrine tumors
Giulia Vocino Trucco and Marco Volante